In myeloma, the expression of antiapoptotic BCL-2 proteins is elevated, thus promoting MM cells’ survival, although the dependence on BCL-2 for cell survival is heterogeneous from one patient with MM to another. Here, BCL2 is linked to plasma cell myeloma.